Table 3.
Analysis for Main Effects |
Analysis for Interactions |
|||
---|---|---|---|---|
Symptom/Exposure | OR | 95% CI | OR | 95% CI |
Cough | ||||
Prenatal ETS | 1.36 | 0.68-2.72 | 1.36 | 0.68-2.72 |
PAH | 1.06 | 0.96-1.18 | 1.03 | 0.91-1.16 |
ETS | 0.59 | 0.30-1.18 | 0.40 | 0.14-1.15 |
PAH × ETS | 1.12 | 0.89-1.40 | ||
Difficulty breathing | ||||
Prenatal ETS | 0.58 | 0.21-1.55 | 0.59 | 0.22-1.62 |
PAH | 1.02 | 0.91-1.15 | 0.88 | 0.68-1.12 |
ETS | 0.54 | 0.20-1.44 | 0.10 | 0.02-0.58† |
PAH × ETS | 1.54 | 1.06-2.22† | ||
Wheeze | ||||
Prenatal ETS | 0.62 | 0.23-1.65 | 0.63 | 0.23-1.70 |
PAH | 1.03 | 0.91-1.16 | 0.84 | 0.59-1.20 |
ETS | 1.66 | 0.63-4.37 | 0.46 | 0.09-2.36 |
PAH × ETS | 1.44 | 0.95-2.18 | ||
Probable asthma | ||||
Prenatal ETS | 0.52 | 0.20-1.34 | 0.48 | 0.17-1.30 |
PAH | 1.08 | 0.97-1.20 | 0.89 | 0.67-1.20 |
ETS | 2.36 | 0.91-6.10 | 0.38 | 0.07-1.99 |
PAH × ETS | 1.64 | 1.10-2.45† |
See Table 2 for definition of terms.
p < 0.05.